Continuum Advisory, LLC Procept Bio Robotics Corp Transaction History
Continuum Advisory, LLC
- $778 Million
- Q3 2024
A detailed history of Continuum Advisory, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Continuum Advisory, LLC holds 12 shares of PRCT stock, worth $885. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12Holding current value
$885% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRCT
# of Institutions
277Shares Held
39.6MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$357 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$257 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$113 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$91.8 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$87.1 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.29B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...